| Assessment Status | Rapid review complete |
| HTA ID | - |
| Drug | Sofosbuvir/Velpatasvir |
| Brand | Epclusa® |
| Indication | For the treatment of chronic hepatitis C virus (HCV) infection in adults |
| Assessment Process | |
| Rapid review commissioned | 12/07/2016 |
| Rapid review completed | 23/08/2016 |
| Rapid review outcome | Full pharmacoeconomic evaluation not recommended for HCV genotype 3 infection |